Pharma Journalist -

Oramed Pharmaceuticals Inc. a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that it has entered into definitive agreements to…
Read More...

SMi Group Reports: Chair of the conference, Justin Mason-Home, personal invitation to join the 5th Annual Highly Potent Active Pharmaceutical Ingredients Conference, on 10-11 May 2021…
Read More...

Pyxis Oncology announced that it has entered into a worldwide license agreement with Pfizer Inc. for the development and commercialization of two antibody-drug conjugate (ADC)…
Read More...

Boston Pharmaceuticals announced a pioneering three-year out-license and option agreement with GlaxoSmithKline PLC. Boston Pharmaceuticals will become a preferred GSK partner for select…
Read More...

Today the Medicines Health Regulatory Authority (MHRA) and European Medicines Agency (EMA) reaffirmed the benefits of COVID-19 Vaccine AstraZeneca continue to far outweigh the risks.…
Read More...

SMi Group Reports: Co-chairs of the conference Michael Scherz and Naheed Mirza personal invitation to join the 21st Annual Pain Therapeutics Conference, taking place virtually this…
Read More...

Ambrx, a clinical stage biopharmaceutical company using an expanded genetic code to create Engineered Precision Biologics, announced that the U.S. Food and Drug Administration (FDA) has…
Read More...

Valence Discovery an emerging leader in AI-enabled drug design, announced it has entered into a drug discovery agreement with Repare Therapeutics, a precision oncology company…
Read More...

Hoth Therapeutics, Inc. a biopharmaceutical company, today announced entering into a Research Agreement with the University of Cincinnati Research Institute ("UCRI") to perform critical…
Read More...

Tonix Pharmaceuticals Holding Corp. a clinical-stage biopharmaceutical company, announced preliminary results following vaccination of non-human primates with TNX-1800 (modified…
Read More...